EVALUATING THE EFFICACY OF SGLT2 INHIBITORS IN MANAGING BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION: A STUDY AT PEMH RAWALPINDI

Authors

  • Dr. Aiman Safdar Author
  • Muhammad Zill-E-Humayun Mirza Author
  • Dr Aishah Ishaque Author
  • Dr. Zainab Ehsan Author
  • Dr. Anum Azeem Author
  • Dr. Shandana Nadeem Author

DOI:

https://doi.org/10.4238/5teyf033

Keywords:

SGLT2 inhibitors, hypertension, type 2 diabete

Abstract

Objectives: To evaluate the efficacy of SGLT2 inhibitors in managing blood pressure in patients with type 2 diabetes and hypertension. Materials and Methods:  After ethical approval and informed consent, 220 eligible patients were enrolled and equally allocated into two groups. Group A received dapagliflozin (10 mg once daily) plus standard therapy, while Group B received standard treatment alone. Baseline demographic and clinical data were collected using a structured questionnaire, and patients were followed for 3 months. Blood pressure was measured at baseline and after 12 weeks to assess efficacy, defined as a reduction of ≥5 mmHg in systolic and/or ≥3 mmHg in diastolic blood pressure. Data were analyzed using SPSS version 25. Results: The mean age was 54.3±7.87 years in Group A and 56.5±7.91 years in Group B. Overall treatment effectiveness was significantly higher in Group A than in Group B (78.2% vs. 49.1%, p<0.001). Stratified analysis also showed significantly greater effectiveness with dapagliflozin across most age, gender, duration of hypertension, duration of diabetes, and BMI subgroups, except among patients with hypertension >10 years, diabetes duration of 1–5 years, and normal BMI, where the differences were not statistically significant. Conclusion: It was concluded that the addition of dapagliflozin to standard therapy was more effective than standard treatment alone in reducing blood pressure in patients with type 2 diabetes mellitus and hypertension. Dapagliflozin may provide additional metabolic and cardiovascular benefits, although larger multicenter studies with longer follow-up are needed to confirm these findings.

Downloads

Published

2026-08-27

Issue

Section

Articles